PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026BMJ Case Reports0 citationsOpen Access

Olmesartan-related sprue-like enteropathy presenting as severe diarrhoea

SSSilvia SuardiMVMarco VicardiCSCarlotta Spillere

Key Points

  • To explore the link between olmesartan and sprue-like enteropathy presenting with severe diarrhoea.
  • Case report of a 60s-year-old woman with a complicated history
  • Initial diagnosis of infectious colitis followed by gastroscopy
  • Serological tests for coeliac disease
  • Monitoring post-medication discontinuation and clinical outcomes.
  • Patient experienced severe diarrhoea and acute renal failure after resuming olmesartan
  • Gastroscopy revealed severe villous atrophy and duodenal inflammation
  • Discontinuation of olmesartan led to clinical improvement without a gluten-free diet.

Abstract

A woman in her 60s with a history of atrial fibrillation, hypertension and dyslipidaemia was admitted to the Intensive Care Unit with hypotension, dehydration and acute kidney injury after 20 days of watery diarrhoea. Although initial investigations did not detect an evident infectious aetiology, a diagnosis of infectious colitis was hypothesised. After supportive care and quick recovery, she was discharged and instructed to resume her prior medications, including olmesartan (used for 1 year) for hypertension. Diarrhoea and renal failure recurred promptly, leading to readmission. Gastroscopy revealed severe villous atrophy and inflammation of the duodenum. However, serological tests for coeliac disease were negative. Olmesartan-related sprue-like enteropathy was diagnosed after discontinuing olmesartan, leading to clinical improvement without a gluten-free diet. This case emphasised the importance of considering iatrogenic causes in severe enteropathy differential diagnosis, particularly olmesartan-related complications in patients presenting with sprue-like symptoms, watery diarrhoea and acute renal failure.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Suardi et al. (2026) studied this question.

synapsesocial.com/papers/6988277b0fc35cd7a8846456https://doi.org/10.1136/bcr-2025-266248
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Severe Spruelike Enteropathy Associated With Olmesartan2012 · 495 citations
  2. 2European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 20202019 · 1,216 citations
  3. 3Olmesartan-associated sprue-like enteropathy2023 · 8 citations
  4. 4European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten‐related disorders2019 · 1,013 citations
  5. 5Olmesartan-associated sprue-like enteropathy2022 · 5 citations